No menu items!

Tag: ImmunoGen

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

Optimizing Enterprise Content Management: The Role of Headless CMS in Streamlining Workflows

Within organizations, companies are overwhelmed with internalized content from...

Navigating Responsible Gambling in Costa Blanca: Balancing Thrills and Safety for Local Bettors

In recent years online gambling platforms have diversified their...

Planning Your Trip to Alicante – How Can Technology Help

This year’s Carnival starts on February 10th, bringing color,...

Tips for Successfully Overcoming Addiction

Overcoming addiction is a challenging but entirely achievable journey....